Role of insulin-like growth factor 1 receptor and c-Src in endothelin-1- and angiotensin II-induced PKB phosphorylation, and hypertrophic and proliferative responses in vascular smooth muscle cells
- PMID: 20029537
- DOI: 10.1139/Y09-056
Role of insulin-like growth factor 1 receptor and c-Src in endothelin-1- and angiotensin II-induced PKB phosphorylation, and hypertrophic and proliferative responses in vascular smooth muscle cells
Abstract
Endothelin-1 (ET-1) and angiotensin II (Ang II) are vasoactive peptides believed to contribute to the pathogenesis of vascular abnormalities such as hypertension, atherosclerosis, hypertrophy, and restenosis. The concept of transactivation of growth factor receptors, such as epidermal growth factor receptor (EGFR), in triggering vasoactive peptide-induced signaling events has gained much recognition during the past several years. We have demonstrated that insulin-like growth factor type 1 receptor (IGF-1R) plays a role in transducing the effect of H2O2, leading to protein kinase B (PKB) phosphorylation. Since vasoactive peptides elicit their responses through generation of reactive oxygen species, including H2O2, we investigated whether IGF-1R transactivation plays a similar role in ET-1- and Ang II-induced PKB phosphorylation and hypertrophic responses in vascular smooth muscle cells (VSMC). AG1024, a specific inhibitor of IGF-1R protein tyrosine kinase (PTK), attenuated both ET-1- and Ang II-induced PKB phosphorylation in a dose-dependent manner. ET-1 and Ang II treatment also induced the phosphorylation of tyrosine residues in the autophosphorylation sites of IGF-1R, which were blocked by AG1024. In addition, both ET-1 and Ang II evoked tyrosine phosphorylation of c-Src, a nonreceptor PTK, whereas pharmacological inhibition of c-Src PTK activity by PP2, a specific inhibitor of Src-family tyrosine kinase, significantly reduced PKB phosphorylation as well as tyrosine phosphorylation of IGF-1R induced by the 2 vasoactive peptides. Furthermore, protein and DNA synthesis enhanced by ET-1 and Ang II were attenuated by AG1024 and PP2. In conclusion, these data suggest that IGF-1R PTK and c-Src PTK play a critical role in mediating PKB phosphorylation as well as hypertrophic and proliferative responses induced by ET-1 and Ang II in A10 VSMC.
Similar articles
-
Activation of insulin-like growth factor type-1 receptor is required for H2O2-induced PKB phosphorylation in vascular smooth muscle cells.Can J Physiol Pharmacol. 2006 Jul;84(7):777-86. doi: 10.1139/y06-024. Can J Physiol Pharmacol. 2006. PMID: 16998541
-
Contribution of epidermal growth factor receptor transactivation in angiotensin II-induced enhanced expression of Gi protein and proliferation in A10 vascular smooth muscle cells.Can J Physiol Pharmacol. 2009 Dec;87(12):1037-45. doi: 10.1139/Y09-089. Can J Physiol Pharmacol. 2009. PMID: 20029540
-
Reactive oxygen species mediate Endothelin-1-induced activation of ERK1/2, PKB, and Pyk2 signaling, as well as protein synthesis, in vascular smooth muscle cells.Free Radic Biol Med. 2004 Jul 15;37(2):208-15. doi: 10.1016/j.freeradbiomed.2004.04.018. Free Radic Biol Med. 2004. PMID: 15203192
-
Insulin-like growth factor type-1 receptor transactivation in vasoactive peptide and oxidant-induced signaling pathways in vascular smooth muscle cells.Can J Physiol Pharmacol. 2007 Jan;85(1):105-11. doi: 10.1139/Y06-101. Can J Physiol Pharmacol. 2007. PMID: 17487250 Review.
-
Involvement of insulin-like growth factor 1 receptor transactivation in endothelin-1-induced signaling in vascular smooth muscle cells.Can J Physiol Pharmacol. 2010 May;88(5):501-9. doi: 10.1139/y10-030. Can J Physiol Pharmacol. 2010. PMID: 20555420 Review.
Cited by
-
Natriuretic peptide receptor-C-mediated attenuation of vascular smooth muscle cell hypertrophy involves Gqα/PLCβ1 proteins and ROS-associated signaling.Pharmacol Res Perspect. 2018 Feb;6(1):e00375. doi: 10.1002/prp2.375. Pharmacol Res Perspect. 2018. PMID: 29417757 Free PMC article.
-
Retinal Surface Macrophage Changes in Thyroid Eye Disease before and after Treatment with Teprotumumab.Case Rep Ophthalmol Med. 2022 Feb 7;2022:5275309. doi: 10.1155/2022/5275309. eCollection 2022. Case Rep Ophthalmol Med. 2022. PMID: 35178261 Free PMC article.
-
Endothelins and their receptors in cancer: identification of therapeutic targets.Pharmacol Res. 2011 Jun;63(6):519-24. doi: 10.1016/j.phrs.2011.01.002. Epub 2011 Jan 18. Pharmacol Res. 2011. PMID: 21251982 Free PMC article. Review.
-
Uremic Toxins and Vascular Calcification-Missing the Forest for All the Trees.Toxins (Basel). 2020 Sep 29;12(10):624. doi: 10.3390/toxins12100624. Toxins (Basel). 2020. PMID: 33003628 Free PMC article. Review.
-
Activation of Akt by advanced glycation end products (AGEs): involvement of IGF-1 receptor and caveolin-1.PLoS One. 2013;8(3):e58100. doi: 10.1371/journal.pone.0058100. Epub 2013 Mar 5. PLoS One. 2013. PMID: 23472139 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Research Materials
Miscellaneous